Haemonetics Corp. diskutieren
Haemonetics Corp.
WKN: 881782 / Symbol: HAE / Name: Haemonetics / Aktie / Ausrüstung & Versorgung / Mid Cap /
62,00 €
-0,80 %
Haemonetics Co. (NYSE: HAE) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Ratings data for HAE provided by MarketBeat
Haemonetics Co. (NYSE: HAE) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Ratings data for HAE provided by MarketBeat
Haemonetics Co. (NYSE: HAE) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Ratings data for HAE provided by MarketBeat
Haemonetics Co. (NYSE: HAE) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Ratings data for HAE provided by MarketBeat
Haemonetics Co. (NYSE: HAE) had its price target lowered by analysts at Barrington Research from $114.00 to $105.00. They now have an "outperform" rating on the stock.
Ratings data for HAE provided by MarketBeat
Haemonetics Co. (NYSE: HAE) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $105.00 price target on the stock.
Ratings data for HAE provided by MarketBeat
Haemonetics Co. (NYSE: HAE) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $105.00 price target on the stock.
Ratings data for HAE provided by MarketBeat
Haemonetics Co. (NYSE: HAE) had its price target raised by analysts at Barrington Research from $105.00 to $107.00. They now have an "outperform" rating on the stock.
Ratings data for HAE provided by MarketBeat
Haemonetics Co. (NYSE: HAE) was upgraded by analysts at Needham & Company LLC from a "hold" rating to a "buy" rating. They now have a $112.00 price target on the stock.
Ratings data for HAE provided by MarketBeat
Haemonetics Co. (NYSE: HAE) is now covered by analysts at BTIG Research. They set a "buy" rating and a $112.00 price target on the stock.
Ratings data for HAE provided by MarketBeat
Haemonetics Co. (NYSE: HAE) is now covered by analysts at CL King. They set a "buy" rating and a $116.00 price target on the stock.
Ratings data for HAE provided by MarketBeat
Haemonetics Co. (NYSE: HAE) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $108.00 price target on the stock.
Ratings data for HAE provided by MarketBeat
Haemonetics Co. (NYSE: HAE) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $108.00 price target on the stock.
Ratings data for HAE provided by MarketBeat
Haemonetics Co. (NYSE: HAE) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $112.00 price target on the stock.
Ratings data for HAE provided by MarketBeat
Haemonetics Co. (NYSE: HAE) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $112.00 price target on the stock.
Ratings data for HAE provided by MarketBeat
Haemonetics Co. (NYSE: HAE) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $108.00 price target on the stock.
Ratings data for HAE provided by MarketBeat
Haemonetics Co. (NYSE: HAE) had its price target lowered by analysts at Needham & Company LLC from $112.00 to $108.00. They now have a "buy" rating on the stock.
Ratings data for HAE provided by MarketBeat
Haemonetics Co. (NYSE: HAE) was downgraded by analysts at Bank of America Co. from a "neutral" rating to an "underperform" rating. They now have a $68.00 price target on the stock, down previously from $95.00.
Ratings data for HAE provided by MarketBeat
Haemonetics Co. (NYSE: HAE) had its price target lowered by analysts at Barrington Research from $108.00 to $95.00. They now have an "outperform" rating on the stock.
Ratings data for HAE provided by MarketBeat
Haemonetics Co. (NYSE: HAE) had its "strong-buy" rating re-affirmed by analysts at Raymond James. They now have a $115.00 price target on the stock, down previously from $120.00.
Ratings data for HAE provided by MarketBeat
Neueste Beiträge
Citigroup_Inc_ in Hewlett Packard Enterprise Co diskutieren